February 7, 2013 - (MRC) - "The Medical Research Council (MRC) has agreed to partner the Californian Institute of Regenerative Medicine (CIRM) in its Disease Team Therapy Development Awards III Request for Applications (RFA 13-01), which aims to progress late preclinical and early clinical translational stem cell research. The MRC is therefore calling for proposals from UK groups active in the late preclinical and early clinical domain that can link to Californian research teams, to establish high quality, multidisciplinary translational research programs." Read Full Press Release
